Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients.

Autor: Glue, Paul1 paul.glue@otago.ac.nz, Cape, Gavin2, Tunnicliff, Donna2, Lockhart, Michelle3, Lam, Fred4, Hung, Noelyn1, Hung, C. Tak4, Harland, Sarah1, Devane, Jane5, Crockett, R. S.6, Howes, John5, Darpo, Borje7,8, Zhou, Meijian7, Weis, Holger5, Friedhoff, Lawrence9
Zdroj: Clinical Pharmacology in Drug Development. Nov/Dec2016, Vol. 5 Issue 6, p460-468. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje